RNS Number:7091J
SSL International PLC
07 April 2003

Board Changes


The Board of SSL International plc announces that Andrew Slater (55), Board
Director responsible for the Group's operations in Europe, has decided to step
down at the end of April 2003 after nearly 21 years with the Group. Garry Watts
(46) will assume responsibility for Europe, as Group Finance Director and
Director Europe.


Ian Martin, Chairman, said:


"Following the Board's strategic decision to dispose of the Medical division and
focus on the Consumer division we are adjusting the management structure to
bring it into line with the size of the group after any disposal.


"The Board is immensely grateful to Andrew for his contribution to the Group
over the years and we wish him well for the future. We are pleased that in
addition to his duties as finance director Garry has agreed to take on
responsibility for Europe. Garry possesses significant operational management
experience and is well equipped for this major role."




FOR MORE INFORMATION:

The Maitland Consultancy                                020 7379 5151
Brian Hudspith
Simone Cheetham




NOTES TO EDITORS:


Garry Watts


Garry Watts was appointed Finance Director of SSL International plc in February
2001. Prior to that he was a board director, with responsibility for
manufacturing, sales and marketing, of Celltech Group plc. He was Finance
Director of Medeva plc, a pharmaceutical group with operations in the USA, UK,
France, Spain, Belgium and Ireland, from 1996 to 2000.


He is a member of the UK's Medicines Control Agency Supervisory Board. He
qualified as a chartered accountant in 1981, became a partner of KPMG in 1990
and is a Fellow of the Chartered Institute of Accountants in England and Wales.





                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAUUUAUCUPWGGM